Dual therapy with Janus kinase inhibitors and biologics for atopic dermatitis: A systematic review
Journal of the European Academy of Dermatology and Venereology · 11.11.2026
DOI: 10.1111/jdv.70855 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 11.11.2026. Verfasst von Jia Qi Adam Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
- School of Medicine, Simon Fraser University, Surrey, British Columbia, Canada.
ORCID-Profile: Jia Qi Adam Bai, Sherilyn Wen, Chaocheng Liu
Zitieren
APA
Bai, J. Q. A., Wen, S., Chen, S., Xu, Y., & Liu, C. (2026). Dual therapy with Janus kinase inhibitors and biologics for atopic dermatitis: A systematic review. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70855
Vancouver
Bai JQA, Wen S, Chen S, Xu Y, Liu C. Dual therapy with Janus kinase inhibitors and biologics for atopic dermatitis: A systematic review. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70855
BibTeX
@article{Bai2026,
author = {Bai, Jia Qi Adam and Wen, Sherilyn and Chen, Shuang and Xu, Yihang and Liu, Chaocheng},
title = {Dual therapy with Janus kinase inhibitors and biologics for atopic dermatitis: A systematic review},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70855}
}
EUVIMED